Volume 32, Issue 1 p. 63-67
Free Access

No effect of probenecid on the renal and biliary clearances of digoxin in man.

A. Hedman

A. Hedman

Department of Clinical Pharmacology, Karolinska Institute, Huddinge University Hospital, Sweden.

Search for more papers by this author
B. Angelin

B. Angelin

Department of Clinical Pharmacology, Karolinska Institute, Huddinge University Hospital, Sweden.

Search for more papers by this author
A. Arvidsson

A. Arvidsson

Department of Clinical Pharmacology, Karolinska Institute, Huddinge University Hospital, Sweden.

Search for more papers by this author
R. Dahlqvist

R. Dahlqvist

Department of Clinical Pharmacology, Karolinska Institute, Huddinge University Hospital, Sweden.

Search for more papers by this author
First published: July 1991
Citations: 8

Abstract

1. The cardiac glycoside digoxin is subject to a number of pharmacokinetic interactions. This study concerns the influence of the anionic transport inhibitor probenecid on the steady-state kinetics of digoxin. 2. Six healthy young men were enrolled in the study. After an administration period of 6 days with digoxin only (0.5 to 1 mg p.o. day- 1) or digoxin in combination with probenecid (2 g p.o. day-1; 8 days), digoxin was administered intravenously (0.7 oral dose) on day 7. Plasma and urine samples were taken over 48 h. The biliary clearance of digoxin was measured during day 8 by a duodenal perfusion technique. 3. Probenecid did not affect the plasma clearance (mean +/- s.d.: 255 +/- 80 vs 266 +/- 40 ml min-1), renal clearance (166 +/- 17 vs 155 +/- 10 ml min-1), biliary clearance (106 +/- 40 vs 111 +/- 50 ml min-1), elimination half-life (34.4 vs 35.2 h) or volume of distribution (538 +/- 241 vs 566 +/- 60 l) of digoxin. 4. Our results suggest that different systems exist in man for the renal and biliary secretion of probenecid and digoxin.